Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 928.2K | -- | 2.55% | -- | 2026-06-30 |
| CHAPIN DAVIS, INC. | 888.0K | -- | 2.44% | -- | 2026-06-30 |
| Apis Capital Advisors, LLC | 804.9K | -- | 2.21% | -466.1K | 2026-06-30 |
| TRUIST FINANCIAL CORP | 326.2K | -- | 0.90% | -- | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 250.9K | -- | 0.69% | -62.6K | 2026-06-30 |
| BlackRock, Inc. | 197.7K | -- | 0.54% | -77.7K | 2026-06-30 |
| CITADEL ADVISORS LLC | 143.1K | -- | 0.39% | +70.2K | 2026-06-30 |
| VANGUARD FIDUCIARY TRUST CO | 139.5K | -- | 0.38% | -- | 2026-06-30 |
| MARATHON CAPITAL MANAGEMENT | 110.0K | -- | 0.30% | -- | 2026-06-30 |
| Sage Mountain Advisors LLC | 106.6K | -- | 0.29% | -- | 2026-06-30 |
